ADC Therapeutics files $300M mixed securities shelf

The company may offer and sell from time to time, in one or more offerings, up to $300M of any combination of the following securities: common shares, debt securities, warrants, subscription rights, purchase contracts and units. The securities may be offered and sold in different series, at times, in amounts, at prices and on terms to be determined at or prior to the time of each offering.